| 99318 |
THE ONCOLOGIST |
Clinical and Economic Burden of Emergency Department Presentations for Neutropenia Following Outpatient Chemotherapy for Cancer in Victoria, Australia |
2012-06-15 |
10.1634/theoncologist.2011-0456 |
Livingston P. M., Craike M., Slavin M. |
| 99317 |
THE ONCOLOGIST |
Faciocutaneous Cancer Syndromes: Spot the Diagnosis |
2012-06-15 |
10.1634/theoncologist.2012-0171 |
Morrison P. J., Ryan P. D. |
| 99316 |
EUROPEAN RADIOLOGY |
Low-dose CT of the lung: potential value of iterative reconstructions. |
2012-06-15 |
10.1007/s00330-012-2524-0 |
Baumueller Stephan, Winklehner Anna, Karlo Christoph, Goetti Robert, Flohr Thomas, Russi Erich W., Frauenfelder Thomas, Alkadhi Hatem |
| 99315 |
THE ONCOLOGIST |
More Than Just Skin Deep: Faciocutaneous Clues to Genetic Syndromes with Malignancies |
2012-06-15 |
10.1634/theoncologist.2012-0033 |
Shen Z., Hoffman J. D., Hao F., Pier E. |
| 99314 |
THE ONCOLOGIST |
Fertility Preservation in Women Undergoing Treatment for Breast Cancer in the U.K.: A Questionnaire Study |
2012-06-15 |
10.1634/theoncologist.2012-0064 |
King J. W., Davies M. C., Roche N., Abraham J. M., Jones A. L. |
| 99313 |
THE ONCOLOGIST |
Leydig Cell Tumor of the Testis in Tuberous Sclerosis: Lack of Second Hit Events |
2012-06-15 |
10.1634/theoncologist.2012-0045 |
Malinowska I. A., Shepherd C. W., Donnelly D. E., Hardy R., Clarke R., Kwiatkowski D. J., Morrison P. J. |
| 99312 |
ONCOLOGY LETTERS |
(-)-Epigallocatechin gallate inhibits the expression of indoleamine 2,3-dioxygenase in human colorectal cancer cells. |
2012-06-15 |
10.3892/ol.2012.761 |
OGAWA KENGO, HARA TAKESHI, SHIMIZU MASAHITO, NAGANO JUNJI, OHNO TOMOHIKO, HOSHI MASATO, ITO HIROYASU, TSURUMI HISASHI, SAITO KUNIAKI, SEISHIMA MITSURU, MORIWAKI HISATAKA |
| 99311 |
ONCOLOGY REPORTS |
A multi-centre randomized, open-label phase II trial of continuous erlotinib plus gemcitabine or gemcitabine as first-line therapy in ECOG PS2 patients with advanced non-small cell lung cancer |
2012-06-15 |
10.3892/or.2012.1871 |
MICHAEL M., PAVLAKIS N., CLINGAN P., DE BOER R., JOHNSTON M., CLARKE S. |
| 99310 |
THE ONCOLOGIST |
Efficacy, Safety, and Biomarkers of Single-Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma |
2012-06-15 |
10.1634/theoncologist.2011-0465 |
Boige V., Malka D., Bourredjem A., Dromain C., Baey C., Jacques N., Pignon J.-P., Vimond N., Bouvet-Forteau N., De Baere T., Ducreux M., Farace F. |
| 99309 |
ONCOLOGY REPORTS |
Suppression of growth of A549 lung cancer cells by waltonitone and its mechanisms of action. |
2012-06-15 |
10.3892/or.2012.1869 |
ZHANG YI, ZHANG GUO-BIN, XU XIAO-MAN, ZHANG MENG, QU DAN, NIU HUI-YAN, BAI XUE, KAN LIANG, HE PING |
